Skip to main content
OpenTrials

Clinical trial condition

Pulmonary Disease, Chronic Obstructive

Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.

4,014 public trials 393 recruiting studies
Refine in advanced search Browse all conditions

Pulmonary Disease, Chronic Obstructive trial results

Completed

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00606684

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Florence, Alabama, United States
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Montgomery, Alabama, United States
  • GSK Investigational Site Fullerton, California, United States
View all 99 locations
View Trial Details
Completed

Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127)

NCT00313209

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Linz, Austria
  • Altana Pharma/Nycomed Investigational Site Neusiedl/See, Austria
  • Altana Pharma/Nycomed Investigational Site Perg, Austria
  • Altana Pharma/Nycomed Investigational Site Salzburg, Austria
View all 134 locations
View Trial Details
Completed

Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS)

NCT01329029

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Nycomed Investigational Site Box Hill, Australia
  • Nycomed Investigational Site Clayton, Australia
  • Nycomed Investigational Site Concord, Australia
  • Nycomed Investigational site Daws Park, Australia
View all 180 locations
View Trial Details
Completed

Advair HFA For Chronic Obstructive Pulmonary Disease(COPD)

NCT00633217

Conditions
Chronic Disease, Disease Attributes, Lung Diseases, +5 more
Locations
  • GSK Investigational Site Jasper, Alabama, United States
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Lafayette, Louisiana, United States
  • GSK Investigational Site New Orleans, Louisiana, United States
View all 16 locations
View Trial Details
Completed

Effect of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Tiotropium: The HELIOS Study (BY217/M2-128)

NCT00424268

Conditions
Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
Locations
  • Altana Pharma/Nycomed Investigational Site Feldbach, Austria
  • Altana Pharma/Nycomed Investigational Site Gänserndorf, Austria
  • Altana Pharma/Nycomed Investigational Site Hallein, Austria
  • Altana Pharma/Nycomed Investigational Site Linz, Austria
View all 103 locations
View Trial Details

Related conditions